FUJIFILM Announces FDA 510(k) Clearance For Latest Innovation In PACS Technology: Synapse5

by PRNewswire

STAMFORD, Conn., Feb. 17, 2016 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc. (a division of FUJIFILM Holdings Corporation OTC: FUJIY), a leading provider of diagnostic imaging products and medical informatics solutions, announced it has received FDA 510(k) clearance for the sale and distribution of its most recent innovation in PACS technology, Synapse 5. The latest offering of Fujifilm's comprehensive Synapse line of solutions –that also includes VNA, 3D, RIS, cardiovascular and mobile offerings – will transform healthcare organizations as they enhance collaboration and optimize workflows across healthcare facilities.  Synapse 5 will be on display at the Healthcare Informatics Management Systems Society (HIMSS) 2016 conference and exhibition held February 29 - March 4, 2016 in Las Vegas, Nevada.

"As reimbursement continues to move from volume-driven to value-based, radiologists need to boost their efficiency, their productivity and their accuracy. The challenge is to be a speed reader who, despite the high velocity, doesn't miss a single abnormality on a single study," said Johann Fernando, Ph.D., chief operating officer at FUJIFILM Medical Systems U.S.A., Inc. "Synapse 5 is designed to help our customers keep up with the changes that have already taken place and, more importantly, to help them stay out ahead of what comes next."

Fujifilm's large base of current PACS customers will be able to take advantage of the speed of Synapse 5 through an upgrade to their current system. It will deliver a server-side, zero-download viewer utilizing a browser-independent desktop experience. Synapse 5 stands to save organizations significant resources due to less desktop management, and a dramatic reduction in bandwidth requirements which many are currently consuming today with last generation PACS technology.

"Synapse 5 has the potential to be a disruptive technology in the PACS market. It truly addresses all of the challenges customers face today from the management of desktop clients to reading large data sets," said Bill Lacy, division vice president of Informatics Marketing and Enterprise Sales at FUJIFILM Medical Systems U.S.A., Inc. "Synapse 5 will provide our customers with solutions to work remotely and across multiple locations and will satisfy the performance demands."

Synapse 5 was introduced at the 2015 scientific assembly and annual meeting of the Radiological Society of North America (RSNA) inChicago, IL.  Synapse 5 will be available for commercial release in the U.S. market in the second half of 2016.

See the full article here.

Save time with kBLASTER's unique result management features of sorting, My Favorites, Saved Search and Search History from a web browser, so either mobile devices or computers can be used to quickly find your primary predicate, multiple predicates or reference devices to build a successful 510(k) clearance strategy. Save money in your 510(k) regulatory strategy and follow-on 510(k) submission spend by enabling self-service extraction of actionable insight from nearly 63,000 FDA medical device 510(k) clearance summaries, plus more than 76,000 splash pages for a total more than 139,000 records.